The New Jersey Academic Detailing Program
Opioid Safety Grand Round
The Opioid Safety Grand Rounds are a biweekly program designed to provide interactive, evidence-based education by participating in a review of a clinical case study related to opioid prescribing, pain, and/or opioid use disorder.
This program is designed to educate New Jersey health care professionals with prescribing authority, including physicians, physician assistants, dentists, podiatrists, optometrists, certified nurse midwives, and advanced practice nurses, as well as licensed pharmacists, psychologists, social workers, professional counselors, marriage and family therapists, and registered nurses and athletic trainers.
Presenters:
James W. Bailey, DO
Director, NeuroMusculoskeletal Institute
Professor and Chair, Department of Rehabilitation Medicine
Aleesa Mobley, Ph.D., APN, CPHQ
NeuroMusculoskeletal Institute
Individual Practice Audits
Join our clinicians for a 1 hour, virtual individual practice audit session. During this session, our team will assess individual needs and needs of the practice. Then we will offer tailored, evidence-based clinical recommendations that are customized to meet the provider's needs. These needs can include; helping them taper patients taking high-risk opioid regimens, promoting non pharmacological treatments for pain management, and increasing the use of medication-assisted treatment and co-prescribing of naloxone for reversal of an overdose for opiate use disorders.
OBJECTIVES:
At the conclusion of this activity, participants will be able to:
- The learner will develop practice policies to ensure urine drug screens on patients prescribed chronic opioid analgesia at least once annually and co-prescribe naloxone for patients prescribed a minimum of 90 daily MME in compliance with state law.
- The learner will utilize the NJ prescription monitoring program as part of standard opioid prescribing practice.
- The learner will perform strategic monitoring and assessment using valid and reliable instruments for potential substance use disorder in patients who are prescribed opioid analgesia.
PLEASE NOTE:
Every provider in the office/practice who would like to receive CME credit must register INDIVIDUALLY. Please be sure to include the name of your office/practice when registering.
CREDITS FOR GRAND ROUNDS (ENDURING):
Rowan-Virtua School of Osteopathic Medicine (Rowan-Virtua SOM) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians.
Rowan-Virtua SOM designates each live activity for a maximum of 1 AOA Category 1-B credit and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
Rowan-Virtua School of Osteopathic Medicine (Rowan-Virtua SOM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Rowan-Virtua SOM designates each live activity for 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CREDITS FOR ACADEMIC DETAILING SESSIONS (LIVE):
Rowan-Virtua School of Osteopathic Medicine (Rowan-Virtua SOM) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians.
Rowan-Virtua SOM designates each live activity for a maximum of 1 AOA Category 1-A credit and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
Rowan-Virtua School of Osteopathic Medicine (Rowan-Virtua SOM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Rowan-Virtua SOM designates each live activity for 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
BOARDS WHO RECOGNIZE THESE COURSES:
- Board of Medical Examiners
- Physician Assistant Advisory Committee
- Board of Nursing
- Board of Dentistry
- Board of Pharmacy
For more information pertaining to the NeuroMusculoskeletal Institute's Research and Grants, please visit go.rowan.edu/nmiresearch
HOW TO REGISTER TO WATCH OPIOID SAFETY GRAND ROUNDS & PRACTICE AUDITS
To register, click on an item link below and then click ADD TO CART. (Note: You are allowed to register for multiple cases.)
Once you have added the item(s) to your cart, please go to your cart and proceed to checkout with payment until you have received confirmation that checkout is complete.
Once you have completed checkout, you will receive an email with instructions on how to access the recorded podcast interview and a receipt of your purchase.
PLEASE NOTE:
Hearing Impaired Registrants: Please note that the recorded Grand Rounds will contain closed captioning.
TECHNICAL SUPPORT, AND OTHER QUESTIONS
For all technical support with registration and access to the modules, please contact the Rowan Online Marketplace Support Center by submit an email ticket here.
For questions pertaining to AOA and ACCME CME credits, please contact CME Office at cme@rowan.edu.
REFUND POLICY
No refunds will be issued once a registrant has logged in to the module. Registrants who have not logged in to the module may request a full refund within 14 days of their date of registration. No refunds will be issued more than 14 days after registration. All refunds are issued directly to the credit card that was used to make the purchase.
Please contact our support services to request a refund, or if you have any registration or technical questions, at 856-256-5560 during the hours of 8 am - 4 pm EST, or click on HELP at the top of the page and complete a support ticket.
UPCOMING LIVE OPIOID SAFETY GRAND ROUNDS
Live Programs: Start May 17, 2023, Reoccur Every 2 Weeks
- Case 1- Cervical Myelopathy: May 17th, 2023
- Case 2- Management of the false positive UDS: May 31, 2023
- Case 3- Shared decision-making: The role of (OMM) in opioid taper: June 28th, 2023
- Case 4- Pseudoaddiction vs. undertreated chronic pain from AVN: July 26th, 2023
- Case 5- Management of opioid-induced hyperalgesia: August 9th, 2023
- Case 6- Managing opioid analgesia in the setting of a SCS: August 30th, 2023
- Case 7- Opioid Tapering in the Geriatric Patient: September 13th, 2023
- Case 8- Opportunities For Opioid Taper In The Difficult Geriatric Patient: October 4th, 2023
- Case 9- When Treating Employment Results In High Dose Opioids: October 25th, 2023
- Case 10- Undertreated Pain Due To Lack Of Patient History: November 15th, 2023
- Case 11- When Chronic Opioid Use Masks Underlying Cardiac Symptoms: December 6th, 2023
- Case 12- Its O.K. To Say No To Increasing Opioid Analgesia: December 20th, 2023
RECORDED OPIOID SAFETY GRAND ROUNDS
Recorded Programs:
- Case 1- Cervical Myelopathy: June 9th, 2023
- Case 2- Management of the false positive UDS: June 23rd, 2023
- Case 3- Shared decision-making: The role of (OMM) in opioid taper: July 7th, 2023
- Case 4- Pseudoaddiction vs. undertreated chronic pain from AVN: August 4th, 2023
- Case 5- Management of opioid-induced hyperalgesia: August 18th, 2023
- Case 6- Managing opioid analgesia in the setting of a SCS: September 8th, 2023
- Case 7- Opioid Tapering in the Geriatric Patient: September 22nd, 2023
- Case 8- Opportunities For Opioid Taper In The Difficult Geriatric Patient: October 13th, 2023
- Case 9- When Treating Employment Results In High Dose Opioids: November 3rd, 2023
- Case 10- Undertreated Pain Due To Lack Of Patient History: November 24th, 2023
- Case 11- When Chronic Opioid Use Masks Underlying Cardiac Symptoms: December 15th, 2023
- Case 12- Its O.K. To Say No To Increasing Opioid Analgesia: December 29th, 2023